Orion OYJ Share Holder Equity 2017-2026 | ORINY

Orion OYJ share holder equity from 2017 to 2026. Share holder equity can be defined as the sum of preferred and common equity items

Orion OYJ share holder equity for the quarter ending June 30, 2026 was $1.475B, a 41.33% increase year-over-year.
Orion OYJ share holder equity for 2025 was $1.453B, a 33.63% increase from 2024.
Orion OYJ share holder equity for 2024 was $1.088B, a 12.89% increase from 2023.
Orion OYJ share holder equity for 2023 was $0.963B, a 0.69% increase from 2022.

Orion OYJ Annual Share Holder Equity (Millions of US $)
2025	$1,453
2024	$1,088
2023	$963
2022	$957
2021	$885
2020	$835
2019	$873
2018	$913
2017	$768
2016	$710

Orion OYJ Quarterly Share Holder Equity (Millions of US $)
2026-06-30	$1,475
2026-03-31	$1,314
2025-12-31	$1,453
2025-09-30	$1,191
2025-06-30	$1,044
2025-03-31	$1,124
2024-12-31	$1,088
2024-09-30	$1,016
2024-06-30	$821
2024-03-31	$768
2023-12-31	$963
2023-09-30	$915
2023-06-30	$837
2023-03-31	$781
2022-12-31	$957
2022-09-30	$979
2022-06-30	$798
2022-03-31	$718
2021-12-31	$885
2021-09-30	$876
2021-06-30	$842
2021-03-31	$758
2020-12-31	$835
2020-09-30	$890
2020-06-30	$782
2020-03-31	$930
2019-12-31	$873
2019-09-30	$792
2019-06-30	$719
2019-03-31	$689
2018-12-31	$913
2018-09-30	$857
2018-06-30	$838
2018-03-31	$638
2017-12-31	$768
2017-09-30	$699
2017-06-30	$605
2017-03-31	$527
2016-12-31	$710

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$12.984B	$2.137B
Orion Oyj is a pharmaceutical company. It develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company's core therapy consists of central nervous system disorders, oncology and respiratory. Its product pipeline includes inhaled Easyhaler(R) pulmonary drugs. Orion Oyj is headquartered in Espoo, Finland.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$68.396B	22.59
Takeda Pharmaceutical (TAK)	Japan	$59.919B	11.13
UCB SA (UCBJY)	Belgium	$45.739B	0.00
Otsuka Holdings, - (OTSKY)	Japan	$39.680B	14.84
BeOne Medicines - (ONC)	Switzerland	$38.041B	61.00
Sandoz Group AG (SDZNY)	Switzerland	$35.464B	0.00
Daiichi Sankyo, - (DSNKY)	Japan	$34.072B	21.27
Zoetis (ZTS)	United States	$30.343B	11.16
Astellas Pharma (ALPMY)	Japan	$26.892B	8.90
United Therapeutics (UTHR)	United States	$21.460B	17.90
Merck (MKKGY)	Germany	$19.487B	15.54
Shionogi (SGIOY)	Japan	$15.947B	9.37
IPSEN (IPSEY)	France	$15.395B	0.00
Neurocrine Biosciences (NBIX)	United States	$15.249B	20.72
Summit Therapeutics (SMMT)	United States	$13.881B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$12.089B	0.00
Corcept Therapeutics (CORT)	United States	$11.979B	263.86
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF)	Italy	$11.965B	15.26
Crinetics Pharmaceuticals (CRNX)	United States	$9.013B	0.00
Eisai (ESAIY)		$8.924B	0.00
Ionis Pharmaceuticals (IONS)	United States	$7.852B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$7.049B	13.27
Stevanato Group S.p.A (STVN)	Italy	$6.523B	32.64
Centessa Pharmaceuticals (CNTA)	United Kingdom	$6.267B	0.00
Oruka Therapeutics (ORKA)	United States	$6.105B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$5.317B	19.36
Grifols, S.A (GRFS)	Spain	$5.009B	0.00
Definium Therapeutics (DFTX)	United States	$4.947B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.923B	0.00
Relay Therapeutics (RLAY)	United States	$4.157B	0.00
Indivior Pharmaceuticals (INDV)	United States	$4.039B	9.38
Enliven Therapeutics (ELVN)	United States	$3.910B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$3.855B	11.93
Amylyx Pharmaceuticals (AMLX)	United States	$3.694B	0.00
Dyne Therapeutics (DYN)	United States	$3.343B	0.00
Hypermarcas (HYPMY)	Brazil	$3.203B	9.10
Soleno Therapeutics (SLNO)	United States	$2.717B	228.83
NewAmsterdam Pharma (NAMS)	Netherlands	$2.529B	0.00
Guardian Pharmacy Services (GRDN)	United States	$2.390B	45.28
Nektar Therapeutics (NKTR)	United States	$2.275B	0.00
Ocular Therapeutix (OCUL)	United States	$2.238B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$2.146B	15.81
Avadel Pharmaceuticals (AVDL)	Ireland	$2.113B	0.00
BioCryst Pharmaceuticals (BCRX)	United States	$2.085B	5.63
Xencor (XNCR)	United States	$1.766B	0.00
KARDIGAN INC (KARD)	United States	$1.735B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.366B	107.00
Harrow (HROW)	United States	$1.269B	0.00
Seaport Therapeutics (SPTX)	United States	$1.229B	0.00
Aktis Oncology (AKTS)	United States	$1.204B	0.00
Cronos Group (CRON)	Canada	$1.179B	29.09
Bioventus (BVS)	United States	$1.093B	17.10
Savara (SVRA)	United States	$1.081B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.993B	0.00
Cybin (HELP)	Canada	$0.992B	0.00
Theravance Biopharma (TBPH)	United States	$0.885B	0.00
Avalo Therapeutics (AVTX)	United States	$0.862B	0.00
Ardelyx (ARDX)	United States	$0.847B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.821B	11.32
Esperion Therapeutics (ESPR)	United States	$0.819B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.773B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.753B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.753B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.750B	0.00
Apnimed (APMD)		$0.711B	0.00
Collegium Pharmaceutical (COLL)	United States	$0.711B	3.13
Zevra Therapeutics (ZVRA)	United States	$0.692B	7.37
Ironwood Pharmaceuticals (IRWD)	United States	$0.671B	5.21
OmniAb (OABI)	United States	$0.630B	0.00
Altimmune (ALT)	United States	$0.628B	0.00
Aquestive Therapeutics (AQST)	United States	$0.604B	0.00
Evotec AG (EVO)	Germany	$0.580B	0.00
ProKidney (PROK)	United States	$0.526B	0.00
Indaptus Therapeutics (INDP)	United States	$0.485B	0.00
Relmada Therapeutics (RLMD)	United States	$0.474B	0.00
ARS Pharmaceuticals (SPRY)	United States	$0.423B	0.00
Larimar Therapeutics (LRMR)	United States	$0.406B	0.00
Prelude Therapeutics (PRLD)	United States	$0.361B	0.00
Century Therapeutics (IPSC)	United States	$0.359B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.339B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.322B	0.00
Avita Medical (RCEL)	United States	$0.314B	0.00
Pyxis Oncology (PYXS)	United States	$0.278B	0.00
USANA Health Sciences (USNA)	United States	$0.275B	15.05
Elite Pharmaceuticals (ELTP)	United States	$0.268B	12.44
Lyell Immunopharma (LYEL)	United States	$0.267B	0.00
Akebia Therapeutics (AKBA)	United States	$0.250B	0.00
Galectin Therapeutics (GALT)	United States	$0.246B	0.00
Nature's Sunshine Products (NATR)	United States	$0.230B	11.17
AleAnna (ANNA)	United States	$0.226B	17.84
Protara Therapeutics (TARA)	United States	$0.222B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.215B	0.00
Siga Technologies (SIGA)	United States	$0.214B	0.00
Journey Medical (DERM)	United States	$0.208B	0.00
Profound Medical (PROF)	Canada	$0.208B	0.00
Korro Bio (KRRO)	United States	$0.207B	0.00
Surrozen (SRZN)	United States	$0.206B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.199B	0.00
Organogenesis (ORGO)	United States	$0.188B	0.00
Minerva Neurosciences (NERV)	United States	$0.183B	0.00
MediWound (MDWD)	Israel	$0.173B	0.00
Atrium Therapeutics (RNA)	United States	$0.173B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.147B	0.00
Innate Pharma SA (IPHYF)	France	$0.138B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.131B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.129B	0.00
VAXART, INC (VXRT)	United States	$0.117B	3.00
Assertio Holdings (ASRT)	United States	$0.116B	0.00
Rafael Holdings (RFL)	United States	$0.111B	0.00
Vivani Medical (VANI)	United States	$0.111B	0.00
Allergy Therapeutics (AGYTF)	United Kingdom	$0.103B	0.00
Cassava Sciences (SAVA)	United States	$0.101B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.099B	0.00
PolyPid (PYPD)	Israel	$0.098B	0.00
HST Global (HSTC)	United States	$0.092B	0.00
ElectroCore (ECOR)	United States	$0.091B	0.00
Fractyl Health (GUTS)	United States	$0.090B	0.00
Nutriband (NTRB)	United States	$0.083B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.083B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.080B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.079B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.078B	0.00
Gain Therapeutics (GANX)	United States	$0.075B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.073B	0.00
Champions Oncology (CSBR)	United States	$0.066B	0.00
Talphera (TLPH)	United States	$0.062B	0.00
Nuo Therapeutics (AURX)		$0.061B	0.00
Heron Therapeutics (HRTX)	United States	$0.060B	0.00
Dominari Holdings (DOMH)	United States	$0.053B	0.00
Veraxa Biotech AG (VRXA)	United States	$0.048B	0.00
SCYNEXIS (SCYX)	United States	$0.044B	0.00
Incannex Healthcare (IXHL)	Australia	$0.041B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Lite Strategy (LITS)	United States	$0.037B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.035B	0.00
Context Therapeutics (CNTX)	United States	$0.033B	0.00
Optimi Health (OPTH)	Canada	$0.029B	0.00
Cosmos Health (COSM)	United States	$0.028B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.027B	0.00
Plus Therapeutics (PSTV)	United States	$0.027B	0.00
TherapeuticsMD (TXMD)	United States	$0.025B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.022B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Lipocine (LPCN)	United States	$0.018B	0.00
Klotho Neurosciences (KLTO)	United States	$0.016B	0.00
Mannatech (MTEX)	United States	$0.016B	0.00
Enlivex (ENLV)	Israel	$0.015B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.015B	0.00
BioVie (BIVI)	United States	$0.015B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.015B	0.00
Vyome Holdings (HIND)	United States	$0.014B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.014B	0.00
Scienture Holdings (SCNX)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.012B	0.00
Natural Alternatives (NAII)	United States	$0.012B	0.00
BioLineRx (BLRX)	Israel	$0.012B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.010B	0.00
Xenetic Biosciences (XBIO)	United States	$0.010B	0.00
Mangoceuticals (MGRX)	United States	$0.009B	0.00
Wellgistics Health (WGRX)	United States	$0.009B	0.00
Traws Pharma (TRAW)	United States	$0.008B	0.00
Inotiv (NOTV)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.007B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.007B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.007B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.006B	0.00
Heatwurx (PCSA)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.005B	0.00
Liminatus Pharma (LIMN)	United States	$0.005B	0.00
Aptorum Group (APM)	United Kingdom	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.004B	0.00
Niki BioSolutions (NIKI)	United Kingdom	$0.004B	0.00
Nuvilex (PMCB)	United States	$0.004B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.004B	0.00
Galmed Pharmaceuticals (EOCN)	Israel	$0.004B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.004B	0.00
Redhill Biopharma (RDHL)	Israel	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.003B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.003B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.003B	0.00
SciSparc (SPRC)	Israel	$0.003B	0.00
Vivos Therapeutics (VVOS)	United States	$0.002B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.002B	0.00
Jaguar Animal Health (JAGX)	United States	$0.001B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.001B	0.00
Clearmind Medicine (CMND)	Canada	$0.001B	0.00
PainReform (PRFX)	Israel	$0.001B	0.00
CDT Equity (CDT)	United States	$0.000B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00